Heidari Zahra, Asadzadeh Reza
Department of Endocrinology and Metabolism, Zahedan University of Medical Sciences, Zahedan, Iran.
School of Biology, Damghan University, Damghan, Iran.
Med J Islam Repub Iran. 2021 Dec 30;35:186. doi: 10.47176/mjiri.35.186. eCollection 2021.
Diabetic retinopathy (DR) is one of the most common complications of diabetes. The known risk factors for microvascular complications are uncontrolled diabetes, duration of diabetes, dyslipidemia, and hypertension. In addition to these conventional risk factors, other risk factors, such as hypothyroidism have recently been suggested. Adult patients with type 2 diabetes mellitus (T2DM) were recruited. All patients were evaluated for retinopathy. Various clinical and biochemical parameters, including thyroid function tests, were assessed and compared between groups. In this study, 928 patients with (T2DM) were included. Of all patients, 376 (40.52%) had DR. In patients with retinopathy, 115 (30.58%) had proliferative and 261 (69.42%) had nonproliferative retinopathy. In patients with nonproliferative DR, 34.48%, 32.95%, and 32.57% had mild, moderate, and severe nonproliferative DR, respectively. Of all patients, 91 (9.8%) had subclinical hypothyroidism. There was a significant relationship between subclinical hypothyroidism (SCH) and DR in these patients. In patients with retinopathy, 14.4% and in patients without retinopathy, 6.7% had SCH (p<0.001). In univariate logistic regression analysis, the chance of developing DR in patients with SCH was 2.33 times higher than patients without subclinical hypothyroidism, each unit increase in the thyroid-stimulating hormone significantly increases the chance of developing DR by 13%. The present study showed that in the population of patients with (T2DM), SCH is associated with DR, regardless of the conventional risk factors.
糖尿病视网膜病变(DR)是糖尿病最常见的并发症之一。已知微血管并发症的危险因素包括糖尿病控制不佳、糖尿病病程、血脂异常和高血压。除了这些传统危险因素外,最近还提出了其他危险因素,如甲状腺功能减退。招募了成年2型糖尿病(T2DM)患者。所有患者均接受视网膜病变评估。评估并比较了各组的各种临床和生化参数,包括甲状腺功能测试。本研究纳入了928例T2DM患者。在所有患者中,376例(40.52%)患有DR。在患有视网膜病变的患者中,115例(30.58%)患有增殖性视网膜病变,261例(69.42%)患有非增殖性视网膜病变。在患有非增殖性DR的患者中,分别有34.48%、32.95%和32.57%患有轻度、中度和重度非增殖性DR。在所有患者中,91例(9.8%)患有亚临床甲状腺功能减退。这些患者中亚临床甲状腺功能减退(SCH)与DR之间存在显著关系。在患有视网膜病变的患者中,14.4%患有SCH,在没有视网膜病变的患者中,6.7%患有SCH(p<0.001)。在单因素逻辑回归分析中,SCH患者发生DR的几率比没有亚临床甲状腺功能减退的患者高2.33倍,促甲状腺激素每增加一个单位,发生DR的几率显著增加13%。本研究表明,在T2DM患者群体中,无论传统危险因素如何,SCH都与DR相关。